|
|
|
Volumn 23, Issue 5 SUPPL. 10, 1996, Pages 72-76
|
|
Gemcitabine in cisplatin-resistant ovarian cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALTRETAMINE;
CA 125 ANTIGEN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
GEMCITABINE;
HEMOGLOBIN;
IFOSFAMIDE;
NUCLEOSIDE ANALOG;
PACLITAXEL;
PLATINUM;
TAXANE DERIVATIVE;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG RESISTANCE;
EDEMA;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
OVARY CANCER;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
ANTINEOPLASTIC AGENTS;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
DEOXYCYTIDINE;
DRUG RESISTANCE;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
|
|
EID: 0029852867
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (38)
|
|
References (0)
|
